|1.||Blackshear, Perry J: 12 articles (05/2014 - 01/2004)|
|2.||Park, Jeong Woo: 10 articles (11/2015 - 04/2010)|
|3.||Cho, Wha Ja: 7 articles (01/2015 - 04/2010)|
|4.||Dixon, Dan A: 7 articles (01/2015 - 01/2003)|
|5.||Yoon, Nal Ae: 6 articles (11/2015 - 05/2012)|
|6.||Sanduja, Sandhya: 6 articles (01/2015 - 05/2009)|
|7.||Lee, Hyun Hee: 6 articles (02/2014 - 04/2010)|
|8.||Cha, Hee Jeong: 5 articles (12/2013 - 04/2010)|
|9.||Lee, Byung Ju: 5 articles (12/2013 - 04/2010)|
|10.||Min, Young Joo: 5 articles (06/2013 - 04/2010)|
05/23/2008 - "Studies in knock-out mice demonstrated roles for three of the family members, tristetraprolin, ZFP36L1, and ZFP36L2, in inflammation, chorioallantoic fusion, and early embryonic development, respectively. "
04/01/2015 - "Tristetraprolin and its role in regulation of airway inflammation."
02/01/2012 - "Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle."
01/01/2011 - "Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation."
01/01/2012 - "The role of tristetraprolin in cancer and inflammation."
01/01/2010 - "This study focused on the ability of diplacone to modulate the gene expression of pro-inflammatory tumour necrosis factor alpha and monocyte chemoattractant protein 1, and of anti-inflammatory zinc finger protein 36. "
01/01/2010 - "In this model, diplacone significantly down-regulated the expression of tumour necrosis factor alpha and monocyte chemoattractant protein 1 and up-regulated the zinc finger protein 36 expression. "
01/01/2010 - "Subsequently, inflammatory reaction was induced by lipopolysaccharide, and changes of tumour necrosis factor alpha, monocyte chemoattractant protein 1 and zinc finger protein 36 gene expression at the transcriptional level were measured. "
08/01/2015 - "Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner."
01/01/2014 - "CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin."
06/01/2013 - "Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells."
09/01/2012 - "Tristetraprolin: roles in cancer and senescence."
08/17/2012 - "Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells."
06/01/2005 - "Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression."
04/01/2004 - "[Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients peripheral blood mononuclear cells stimulated with lipopolysaccharide]."
01/01/2011 - "miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization."
01/01/2008 - "Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals."
06/01/2004 - "To determine the significance of tristetraprolin (TTP) gene expression in synovial tissues of patients with rheumatoid arthritis (RA). "
|5.||Breast Neoplasms (Breast Cancer)
12/08/2015 - "Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway."
05/30/2014 - "Tristetraprolin represses estrogen receptor α transactivation in breast cancer cells."
07/22/2010 - "The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes."
04/01/2013 - "Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages."
06/15/2009 - "Analyses of gene array data sets revealed that suppression of tristetraprolin expression is a negative prognostic indicator in breast cancer, because patients with low tumor tristetraprolin mRNA levels were more likely to present increased pathologic tumor grade, vascular endothelial growth factor expression, and mortality from recurrent disease. "
|1.||thymidine 5'-triphosphate (TTP)
|2.||Proteins (Proteins, Gene)
|3.||p38 Mitogen-Activated Protein Kinases
|4.||Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
|5.||Protein Kinases (Protein Kinase)
|6.||Messenger RNA (mRNA)
|7.||RNA-Binding Proteins (RNA-Binding Protein)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)